NASDAQ:BLFS
BioLife Solutions Stock News
$17.48
-0.0600 (-0.342%)
At Close: May 01, 2024
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
BioLife Solutions (NASDAQ:BLFS) Stock Rating Upgraded by BidaskClub
05:38am, Sunday, 19'th Jul 2020
BidaskClub upgraded shares of BioLife Solutions (NASDAQ:BLFS) from a hold rating to a buy rating in a research note released on Wednesday morning, BidAskClub reports. Other equities analysts also rece
BioLife Solutions evo® Cold Chain Management Platform Now Supporting Over 100 Early Stage Cell & Gene Therapy Clinical Trials
12:00pm, Wednesday, 15'th Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided a
Week 29 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
11:58pm, Sunday, 12'th Jul 2020
Two new sample MDA Breakout Stocks for Week 29 with better than 10% short-term upside potential and now up an average 152.47% YTD.
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
04:45pm, Tuesday, 07'th Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Moving Average Crossover Alert: BioLife Solutions
01:08pm, Monday, 06'th Jul 2020
BioLife Solutions, Inc. (BLFS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
BioLife (BLFS) Catches Eye: Stock Jumps 12.1%
10:57am, Monday, 06'th Jul 2020
BioLife (BLFS) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tiziana Life Sciences (TLSA –
Here's Why BioLife Solutions Jumped Higher Today
06:48pm, Thursday, 02'nd Jul 2020
It doesn't look like the COVID-19 pandemic had much effect on sales of the company's bioproduction products for cell and gene therapies.
BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock
11:40am, Thursday, 02'nd Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
AbbVie Inc (NYSE: ABBV)
ADC...
BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020
08:02pm, Wednesday, 01'st Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
BioLife Solutions Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 01'st Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
